InsidersTradesSigma
Track the 이연제약 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 이연제약 has logged 37 public disclosures. Market capitalisation: €179.7bn. The latest transaction was reported on 12 March 2026 (Other). Among the most active insiders: 정순옥. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
25 of 37 declarations
이연제약 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and manufacturing of innovative medications.